Skip to main content

Advertisement

Table 1 Clinical characteristics of healthy controls and HAE patients

From: Deciphering the metabolic perturbation in hepatic alveolar echinococcosis: a 1H NMR-based metabolomics study

Parameter HAE group Control group
n (%) Mean ± SD n (%) Mean ± SD
Age (years) 18 32 ± 12 18 34 ± 12
Male 9 (50.0) 12 (66.7)
Female 9 (50.0) 6 (33.3)
BMI (kg/m2) 18 20.80 ± 2.96 18 22.00 ± 2.32
Lesion short diameter (cm) 18 10.09 ± 2.43
Lesion long diameter (cm) 18 12.74 ± 3.41
P1N0M0 2 (11.1)
P2N0M0 8 (44.4)
P2N1M0 5 (27.8)
P3N1M1 1 (5.6)
P4N1M0 1 (5.6)
P4N1M1 1 (5.6)
WBC (×109/l) 18 7.80 ± 3.69
PLT (×109/l) 18 296.06 ± 125.73
HB (g/l) 18 119.87 ± 33.13
PT (s) 18 13.20 ± 3.16
TB (µmol/l) 18 46.03 ± 49.06
ALT (U/l) 18 49.17 ± 58.40
ALP (U/l) 18 349.26 ± 332.27
ALB (g/l) 18 33.35 ± 4.04
  1. Abbreviations: BMI, body mass index; PNM, parasite location within the liver, neighbouring organ involvement, metastases; WBC, white blood cells; PLT, blood platelets; HB, haemoglobin; PT, prothrombin time; TB, total bilirubin; ALT, alanine aminotransferase; ALP, alkaline phosphatase; ALB, albumin; SD, standard deviation